Remedium Capital Partners, LLC
CIK 0002104501 · WEST PALM BEACH, FL · Quarter end: 2026-06-30 · Filed on: 2026-08-07 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$451.6M
2026 Q2
Positions
6
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
100.0%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
ORKA
Oruka Therapeutics Inc
33.0%
SYRE
Spyre Therapeutics Inc
28.8%
03770N101
Apogee Therapeutics Inc
17.2%
36322Q206
Damora Therapeutics Inc
11.8%
JBIO
Jade Biosciences Inc
7.8%
CBIO
Crescent Biopharma Inc
1.4%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.